OneSource Specialty Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹290.34 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.73 per cent from ₹375.76 crore. This corresponds to a year-on-year *(YoY) decline of 26.04 per cent.
Operating Profit
Operating Profit stands at ₹42.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.84 per cent from ₹37.00 crore. This corresponds to a year-on-year *(YoY) decline of 18.42 per cent.
PBDT
PBDT stands at ₹65.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.37 per cent from ₹65.09 crore. This corresponds to a year-on-year *(YoY) decline of 8.14 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-93.01 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1,717.57 per cent from ₹5.75 crore. This corresponds to a year-on-year *(YoY) growth of 39.86 per cent.
Net Profit
Net Profit stands at ₹-81.61 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 877.98 per cent from ₹10.49 crore. This represents a 357.69 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
OneSource Specialty Pharma Ltd News
OneSource Specialty Pharma Ltd Earnings
- YOY
- QOQ
OneSource Specialty Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
OneSource Specialty Pharma Ltd Research Reports
OneSource Specialty Pharma Ltd Financial Reports
OneSource Specialty Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| OneSource Speci. | -18.75% | -29.14% | -34.04% | -35.86% | -41.66% | -24.25% |
| Cohance Life | -1.69% | -2.41% | -29.55% | -56.12% | -62.38% | -61.59% |
| Acutaas Chemical | 4.30% | 7.62% | 4.12% | 0.42% | 49.29% | 83.00% |
| Granules India | 2.34% | 7.69% | -4.17% | 1.51% | 24.88% | 11.81% |
| Caplin Point Lab | 0.46% | -0.67% | -8.15% | -14.12% | -15.68% | -8.89% |
| Concord Biotech | -1.79% | -0.51% | -8.44% | -14.56% | -34.45% | -39.70% |
| Alivus Life | 0.49% | 2.64% | -1.49% | -2.19% | -13.73% | -23.38% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Managing Director & CEO : Neeraj Sharma
Independent Non Exe. Director : Debarati Sen
Independent Non Exe. Director : Claudio Albrecht
Independent Non Exe. Director : Rashmi Harshadrai Barbhaiya
Independent Non Exe. Director : Vijay Paul Karwal
Independent Non Exe. Director : Colin Michael Bond
Non Executive Director : Bharat Shah
Company Sec. & Compli. Officer : Trisha A